JBIO vs. ANGPY
JBIO (Jade Biosciences, Inc) and ANGPY (Anglo American Platinum ADR) are both stocks. JBIO operates in Biotechnology (Healthcare), while ANGPY operates in Other Precious Metals & Mining (Basic Materials). Over the past 3 years, JBIO returned 126.60%/yr vs 20.94%/yr for ANGPY. At a 0.13 correlation, their price movements are largely independent.
Performance
JBIO vs. ANGPY - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, JBIO achieves a 26.05% return, which is significantly higher than ANGPY's -11.75% return.
JBIO
- 1D
- 15.64%
- 1M
- -12.43%
- YTD
- 26.05%
- 6M
- 15.29%
- 1Y
- 96.66%
- 3Y*
- 126.60%
- 5Y*
- —
- 10Y*
- —
ANGPY
- 1D
- -5.61%
- 1M
- -7.72%
- YTD
- -11.75%
- 6M
- -13.78%
- 1Y
- 81.32%
- 3Y*
- 20.94%
- 5Y*
- -1.14%
- 10Y*
- 17.81%
JBIO vs. ANGPY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
JBIO Jade Biosciences, Inc | 26.05% | 5,473.10% | -88.29% | -22.76% | 148.52% | -57.89% |
ANGPY Anglo American Platinum ADR | -11.75% | 202.15% | -40.10% | -34.38% | -19.08% | 9.70% |
Correlation
The correlation between JBIO and ANGPY is 0.16, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.16 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.15 |
Correlation (All Time) Calculated using the full available price history since Jun 30, 2021 | 0.13 |
Fundamentals
JBIO:
$1.12B
ANGPY:
$18.92B
JBIO:
-$2.96
ANGPY:
ZAR 13.76
JBIO:
3.79
ANGPY:
3.15
JBIO:
$0.00
ANGPY:
ZAR 221.81B
JBIO:
-$9.00K
ANGPY:
ZAR 45.66B
JBIO:
-$133.57M
ANGPY:
ZAR 50.68B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
JBIO vs. ANGPY — Risk / Return Rank
JBIO
ANGPY
JBIO vs. ANGPY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Jade Biosciences, Inc (JBIO) and Anglo American Platinum ADR (ANGPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| JBIO | ANGPY | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.05 | ||
| Sortino ratioReturn per unit of downside risk | +0.24 | ||
| Omega ratioGain probability vs. loss probability | 1.24 | 1.22 | +0.02 |
| Calmar ratioReturn relative to maximum drawdown | 2.20 | 1.99 | +0.20 |
| Martin ratioReturn relative to average drawdown | 4.83 | 4.77 | +0.06 |
Loading charts...
Drawdowns
JBIO vs. ANGPY - Drawdown Comparison
The maximum JBIO drawdown since its inception was -95.41%, which is greater than ANGPY's maximum drawdown of -78.47%. Use the drawdown chart below to compare losses from any high point for JBIO and ANGPY.
Loading charts...
Drawdown Indicators
| JBIO | ANGPY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -95.41% | -78.47% | -16.94% |
Max Drawdown (1Y)Largest decline over 1 year | -44.21% | -40.99% | -3.22% |
Max Drawdown (3Y)Largest decline over 3 years | -95.41% | -42.25% | -53.16% |
Max Drawdown (5Y)Largest decline over 5 years | — | -78.47% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -78.47% | — |
Current DrawdownCurrent decline from peak | -27.56% | -41.32% | +13.76% |
Average DrawdownAverage peak-to-trough decline | -45.13% | -35.16% | -9.97% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 20.10% | 17.11% | +2.99% |
Volatility
JBIO vs. ANGPY - Volatility Comparison
Jade Biosciences, Inc (JBIO) has a higher volatility of 28.03% compared to Anglo American Platinum ADR (ANGPY) at 23.73%. This indicates that JBIO's price experiences larger fluctuations and is considered to be riskier than ANGPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| JBIO | ANGPY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 28.03% | 23.73% | +4.30% |
Volatility (6M)Calculated over the trailing 6-month period | 54.75% | 56.24% | -1.49% |
Volatility (1Y)Calculated over the trailing 1-year period | 78.78% | 68.97% | +9.81% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 1,584.51% | 58.91% | +1,525.60% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 1,584.51% | 57.16% | +1,527.35% |
Dividends
JBIO vs. ANGPY - Dividend Comparison
JBIO has not paid dividends to shareholders, while ANGPY's dividend yield for the trailing twelve months is around 3.65%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
ANGPY Anglo American Platinum ADR | 3.65% | 3.87% | 3.40% | 4.85% | 15.62% | 10.20% | 2.91% | 0.99% | 1.11% |
JBIO Jade Biosciences, Inc | 0.00% | 15.55% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
JBIO vs. ANGPY - Financials Comparison
This section allows you to compare key financial metrics between Jade Biosciences, Inc and Anglo American Platinum ADR. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
JBIO and ANGPY have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
JBIO has higher volatility (28.03%) compared to ANGPY (23.73%). In terms of maximum drawdown, JBIO dropped -95.41% vs ANGPY's -78.47%.
JBIO currently has the higher Sharpe Ratio (1.24 vs 1.19), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for JBIO and ANGPY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer